67 related articles for article (PubMed ID: 22421449)
1. Administration of the PARP inhibitor Pj34 ameliorates the impaired vascular function associated with eNOS(-/-) mice.
English FA; McCarthy FP; Andersson IJ; Stanley JL; Davidge ST; Baker PN; Walsh SK; Kenny LC
Reprod Sci; 2012 Aug; 19(8):806-13. PubMed ID: 22421449
[TBL] [Abstract][Full Text] [Related]
2. eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype.
Kusinski LC; Stanley JL; Dilworth MR; Hirt CJ; Andersson IJ; Renshall LJ; Baker BC; Baker PN; Sibley CP; Wareing M; Glazier JD
Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(1):R86-93. PubMed ID: 22552791
[TBL] [Abstract][Full Text] [Related]
3. Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia.
Walsh SK; English FA; Crocker IP; Johns EJ; Kenny LC
Br J Pharmacol; 2012 Aug; 166(7):2109-16. PubMed ID: 22339234
[TBL] [Abstract][Full Text] [Related]
4. Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia.
Crocker IP; Kenny LC; Thornton WA; Szabo C; Baker PN
Br J Pharmacol; 2005 Mar; 144(6):772-80. PubMed ID: 15778700
[TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase deficiency reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant mice.
Kulandavelu S; Whiteley KJ; Qu D; Mu J; Bainbridge SA; Adamson SL
Hypertension; 2012 Jul; 60(1):231-8. PubMed ID: 22615111
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
7. Effect of prenatal hypoxia in transgenic mouse models of preeclampsia and fetal growth restriction.
Rueda-Clausen CF; Stanley JL; Thambiraj DF; Poudel R; Davidge ST; Baker PN
Reprod Sci; 2014 Apr; 21(4):492-502. PubMed ID: 24084523
[TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
[TBL] [Abstract][Full Text] [Related]
9. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I
Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597
[TBL] [Abstract][Full Text] [Related]
10. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging.
Pacher P; Mabley JG; Soriano FG; Liaudet L; Szabó C
Int J Mol Med; 2002 Jun; 9(6):659-64. PubMed ID: 12011985
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Vasodilator Property of Poly(ADP-Ribose) Polymerase Inhibitor (PJ34) in the Neonatal and Adult Mouse Is Mediated by the Nitric Oxide Pathway.
Bonnin P; Charriaut-Marlangue C; Pansiot J; Boutigny A; Launay JM; Besson VC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911782
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
[TBL] [Abstract][Full Text] [Related]
13. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.
Szabó G; Soós P; Bährle S; Zsengellér Z; Flechtenmacher C; Hagl S; Szabó C
Eur J Cardiothorac Surg; 2004 May; 25(5):825-32. PubMed ID: 15082289
[TBL] [Abstract][Full Text] [Related]
14. Postpartum reversal of the pregnancy-induced uterine artery remodeling in young, aging, and eNOS-deficient mice.
van der Heijden OW; Essers YP; Wijnands E; Mey JG; Peeters LL; van Eys GJ
Reprod Sci; 2009 Jul; 16(7):642-9. PubMed ID: 19351963
[TBL] [Abstract][Full Text] [Related]
15. [Researched of PJ34 which is protective effect on the glutamate-induced HT-22 cell damage].
Fan HB; Wang YN; Geng DQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):712-3. PubMed ID: 20862804
[TBL] [Abstract][Full Text] [Related]
16. PJ34, a poly adenosine diphosphate-ribose polymerase inhibitor, attenuates chromate-induced nephrotoxicity.
Yam-Canul P; Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):483-8. PubMed ID: 18331393
[TBL] [Abstract][Full Text] [Related]
17. Pneumonia-induced sepsis and gut injury: effects of a poly-(ADP-ribose) polymerase inhibitor.
Lobo SM; Orrico SR; Queiroz MM; Cunrath GS; Chibeni GS; Contrin LM; Cury PM; Burdmann EA; de Oliveira Machado AM; Togni P; De Backer D; Preiser JC; Szabó C; Vincent JL
J Surg Res; 2005 Dec; 129(2):292-7. PubMed ID: 16139303
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone-induced endothelial dysfunction of rat aorta: role of poly(ADP-ribose) activation.
Tasatargil A; Tekcan M; Celik-Ozenci C; Ece Gungor N; Dalkiran B
J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):127-37. PubMed ID: 19713411
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow.
Fatini C; Sticchi E; Gensini F; Genuardi M; Tondi F; Gensini GF; Riviello C; Parretti E; Mello G; Abbate R
J Hypertens; 2006 Sep; 24(9):1823-9. PubMed ID: 16915032
[TBL] [Abstract][Full Text] [Related]
20. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
